LOAN AGREEMENT dated as of August 11, 2017 among PERKINELMER, INC. The Lenders Party Hereto and JPMORGAN CHASE BANK, N.A. as Administrative Agent JPMORGAN CHASE BANK, N.A., as Sole Bookrunner and Sole Lead ArrangerLoan Agreement • August 15th, 2017 • Perkinelmer Inc • Laboratory analytical instruments • New York
LOAN AGREEMENT (this “Agreement”) dated as of August 11, 2017 among PERKINELMER, INC., the LENDERS from time to time party hereto and JPMORGAN CHASE BANK, N.A., as Administrative Agent.
AMENDMENT NO. 1 Dated as of August 11, 2017 to CREDIT AGREEMENT Dated as of August 11, 2016Credit Agreement • August 15th, 2017 • Perkinelmer Inc • Laboratory analytical instruments • New York
THIS AMENDMENT NO. 1 (this “Amendment”) is made as of August 11, 2017 by and among PerkinElmer, Inc., a Massachusetts corporation (the “Company”), Wallac Oy, a Finnish limited liability company with business identity code 0937168-4 (“Finnish Borrower”), PerkinElmer Health Sciences, Inc., a Delaware corporation (“Health Sciences” and, together with the Company and the Finnish Borrower, the “Borrowers”), the financial institutions listed on the signature pages hereof and JPMorgan Chase Bank, N.A., as Administrative Agent (the “Administrative Agent”), under that certain Credit Agreement dated as of August 11, 2016 by and among the Borrowers, the other Subsidiary Borrowers from time to time party thereto, the Lenders and the Administrative Agent (as amended, restated, supplemented or otherwise modified from time to time, the “Credit Agreement”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings given to them in the Credit Agreement.
